Core Alternative Capital
Source: SEC Form 13F · as of Mar 2026Core Alternative Capital holds 16 biotech & pharma companies tracked by BioSniper, totaling $26.0M in value as of Mar 2026 (SEC Form 13F).
Companies held
16
Total value held
$26.0M
| Company | Shares | Value |
|---|---|---|
| JNJJOHNSON & JOHNSON | 39,298 | $9.6M |
| LLYELI LILLY & Co | 8,484 | $7.8M |
| MRKMerck & Co., Inc. | 43,783 | $5.3M |
| AMGNAMGEN INC | 3,321 | $1.2M |
| ABBVAbbVie Inc. | 2,512 | $546K |
| PMPhilip Morris International Inc | 2,030 | $336K |
| PFEPFIZER INC | 11,613 | $326K |
| UNHUnitedHealth Group Incorporated Common Stock (DE) | 1,062 | $287K |
| GILDGILEAD SCIENCES, INC. | 1,870 | $261K |
| ABTABBOTT LABORATORIES | 2,320 | $238K |
| VRTXVERTEX PHARMACEUTICALS INC / MA | 123 | $55K |
| MCKMcKesson Corporation | 47 | $41K |
| BMYBRISTOL MYERS SQUIBB CO | 620 | $38K |
| GEHCGE HealthCare Technologies Inc. | 225 | $16K |
| VTRSViatris Inc | 922 | $12K |
| TGTXTG THERAPEUTICS, INC. | 180 | $6K |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.